Angiotensin-(1–7) may inhibit the MAPK and NF-κB signaling pathways, delaying inflammatory joint damage and myocardial fibrosis and activating the downstream TGF-/Smad pathway [53]. Here, NFKB1 is linked to Myocardial fibrosis.